Your browser doesn't support javascript.
loading
[Legionella and Legionellosis]. / Legionella und Legionellose.
Kolditz, Martin; Lück, Christian.
Afiliação
  • Kolditz M; Abteilung für Pneumologie, Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden.
  • Lück C; Institut für Medizinische Mikrobiologie und Hygiene/Institut für Virologie, Medizinische Fakultät "Carl Gustav Carus", Technische Universität Dresden.
Dtsch Med Wochenschr ; 144(15): 1030-1033, 2019 08.
Article em De | MEDLINE | ID: mdl-31350743
ABSTRACT
Diagnosed and reported Legionella pneumonias are slightly increasing during recent years. This might at least partially be due to more frequently used diagnostic tests.In severe pneumonia, nucleic acid amplification based methods should supplement the L. pneumophila serogroup-1 urinary antigen test because of their improved spectrum and sensitivity.Recent in vitro data suggest enhanced efficacy of levofloxacin when compared to macrolides. This complements recent clinical cohort data. Thus levofloxacin (750-1000 mg/d) is regarded the treatment of choice for confirmed legionellosis. Second line options are azithromycin or moxifloxacin. Treatment duration of 7 days should be sufficient in most cases.Development of resistance is rare and no routine resistance testing is necessary.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Legionelose / Legionella / Antibacterianos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: De Revista: Dtsch Med Wochenschr Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Legionelose / Legionella / Antibacterianos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: De Revista: Dtsch Med Wochenschr Ano de publicação: 2019 Tipo de documento: Article
...